Skip to content

DR. ANNE SCHUERMANS

Active Private limited companyfounded 2020active for 5 yearsMatenstraat 19A, 3600 GenkKBO/BCE: BE 0760.721.411

Lifetime

5 annual accounts with figures on one time axis
peak of €58,725 in 2023
€52,555▲ 30.2%
peak of €44,847 in 2023
€24,437▲ 17.3%
peak of €94,109 in 2023
€30,437▲ 13.4%
€87,242▲ 14.3%
Board1 name since 2020
1 director
Documentsfilings and deeds
17-08-202617 days late
2025micro format
Gross margin from €40,366 to €52,555Dividend €20,839Equity from €26,839 to €30,437Cash from €9,870 to €31,147

Key points

from the 2025 annual accounts

Equity

€30,437 from €94,109 in 2023

Equity fell by 68% in 2 years.

Debts

€87,242 74% of the balance sheet
Financial debts 28%Suppliers 2%Taxes and wages 4%Other 66%

Of this, €62,801 falls due within a year.

Filings

5 annual accounts 2 late
AprilJune31 JulyOctober20222024

The 2021 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as DR. ANNE SCHUERMANS has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for DR. ANNE SCHUERMANS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 31-12-2020
  • founderdeed of 05-01-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0760721411
Registered office moved within Genk The registered office moved from Emiel Van Dorenlaan 70 bus 21, 3600 Genk to Matenstraat 19a, 3600 Genk · Board meeting of 28-03-2022 · Gazette deed
Incorporation Founding capital of €6,000, 100 shares · Founded by · appointed as director · published on 05-01-2021 · Gazette deed
First establishment Processiestraat 16, Bilzen-Hoeselt
All 11 events

Comparable companies

same main activity, similar in size and age
Company
DR. ANNE SCHUERMANS Genk €117,678 €52,555 25.9% -
CABINET EL ASKRI Seneffe €115,143 €52,510 82.6% -
Dr. Geys Michèle Mortsel €109,438 €53,787 34.7% -
Docteur Benoît DEWART Namur €125,959 €51,817 21.9% -
SYKLI - HUISARTS Bekkevoort €107,643 €49,119 1.4% -
Manouk Lauwers Ranst €110,820 €52,065 39.3% -
Société d'Assistance Médicale Rixensart €121,077 €52,255 74.5% -

These companies have the same main activity as DR. ANNE SCHUERMANS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €108,000 and €126,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 31-12-2020Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.311.482.5813740 Bilzen-Hoeselt, since 31-12-2020
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €120,000estimated
€117,678▲ 14.1%
Filing
Filed on 17-08-2026
Financials

Insights on DR. ANNE SCHUERMANS

DR. ANNE SCHUERMANS files the micro format. That format states no turnover. The gross margin rose from €27,343 in 2021 to €52,555 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. ANNE SCHUERMANS

What is the company number of DR. ANNE SCHUERMANS?
The company number of DR. ANNE SCHUERMANS is 0760.721.411. The VAT number is the same number with BE in front: BE 0760.721.411.
Where is DR. ANNE SCHUERMANS based?
The registered office is at Matenstraat 19A, 3600 Genk.Company details
What does DR. ANNE SCHUERMANS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. ANNE SCHUERMANS?
DR. ANNE SCHUERMANS is a private limited company (BV).
When was DR. ANNE SCHUERMANS founded?
DR. ANNE SCHUERMANS was founded on 31-12-2020.
Is DR. ANNE SCHUERMANS still active?
Yes, DR. ANNE SCHUERMANS is an active enterprise in the KBO register.
What is the turnover of DR. ANNE SCHUERMANS?
The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €52,555 and 33 comparable companies (NACE 862). It probably lies between €89,000 and €150,000.Financials
Is DR. ANNE SCHUERMANS profitable?
In financial year 2025, DR. ANNE SCHUERMANS made a profit of €24,437.
Where can I find the annual accounts of DR. ANNE SCHUERMANS?
DR. ANNE SCHUERMANS filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. ANNE SCHUERMANS due?
DR. ANNE SCHUERMANS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.